Stay updated on Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page. This appears to be a metadata/version update and does not change study content or eligibility information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This update reflects a metadata revision on the page and does not modify study details or eligibility.SummaryDifference0.1%

- Check49 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2 without changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1; this appears to be a minor metadata update with no changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a glossary toggle and QC-related metadata labels (Last Update Submitted that Met QC Criteria) along with a revision tag (Revision: v3.4.0). These are UI/metadata updates rather than changes to core study content.SummaryDifference0.2%

- Check78 days agoChange DetectedRevision label updated to v3.3.4 and the previous label v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.